<DOC>
	<DOCNO>NCT01384006</DOCNO>
	<brief_summary>To expand donor pool pancreas allografts . For detailed description please see .</brief_summary>
	<brief_title>Extended Pancreas Donor Program - The EXPAND Study</brief_title>
	<detailed_description>This investigator initiate prospective , non-randomized feasibility-study , compare recipient EDC-pancreas allograft ( SPK PTA ) patient undergo SPK PTA standard criterion allograft . Simultaneous Pancreas Kidney transplantation ( SPK ) Pancreas Transplantation alone ( PTA ) life save procedure patient type 1 ( juvenile ) diabetes mellitus impaired renal function . Although wait list SPK PTA increase , number pancreas transplantation decline Eurotransplant ( ET ) area ( www.eurotransplant.nl ) . One major reason decline fact large number pancreas allograft , potentially eligible transplantation exclude ET pancreas allocation system ( EPAS ) . Those criterion include organ-specific cut-off donor age &gt; 50 year and/or BMI &gt; 30 . This mean donor old 50 year donor BMI &gt; 30 , moment , consider solid organ transplantation . The pancreas directly allocate islet transplantation ( Eurotransplant manual - version may 26 , 2009 ) . The organ-specific cut-off establish provide donor pancreas islet transplantation . Although 173 pancreas allocate retrieved islet transplantation 17 islet transplantation perform whole ET area 2008 ( ET data ) . In Germany two islet transplantation perform 2009 . Best result islet transplantation achieve organ obtain young obese donor . Concerning allocation , conflict interest exist whole organ islet transplantation , single active German islet center take part EXPAND study . Meanwhile , accord suggestion EXPAND study group , extend donor pancreas intend offer regionally `` rescue '' allocation center . The center decide organ transplant whole organ use islet . As average age post mortal organ donor ET area 58 year , severe donor selection age lead organ shortage . In Germany 2008 total number organ donor 1.198 . However , 510 donor age 3 50 year thus potentially eligible pancreas donation . Out 510 donor 183 pancreas ( 36 % potential , age restrict pancreas donor ) retrieve 127 ( 25 % ) transplant ( DSO , Deutsche Stiftung für Organtransplantation e.V. ) . Altogether , 676 donor even screen pancreas donation due age , regardless medical condition . In addition , approximately 13 % eligible pancreas donation due BMI . Moreover , ET-area pancreas allocate without local priority lead long ischemic time due transport way . However , data allocation area throughout world ( UNOS UK ) show good overall outcome PTx achieve donor exceed define allocation criterion define ET ( old 50 BMI &gt; 30 ) , cold ischemic time keep short . In Great Britain , local retrieval allocation system installed 2000 result steep increase pancreas transplantation . Moreover , within new allocation system currently worldwide large successful pancreas transplant program initiate Oxford 2004 extensive use extend pancreas donor lead excellent result . These extend criterion avoid donor BMI restriction , accept donor age 8 68 year . Meanwhile 350 SPK PTA transplant excellent one year pancreas survival 91 % , kidney survival 95 % patient survival 96 % . In US , retrospective analysis OPTN registry compare 8.850 SPK young donor vs. 776 SPK donor &gt; 45 year . It show patient transplant old donor equal survival compare wait young donor 1.5 year . However earlier transplant patient instantly dialysis insulin . Good result already achieve extended pancreas donor US also one German study . Based finding , new pancreas allocation system establish USA standard pancreas ( donor age &lt; 50y BMI &lt; 30 ) allocate first local , regional national level extend pancreas ( donor age &gt; 50 year BMI &gt; 30 ) allocate locally . In conclusion , data indicate requirement new allocation system also ET area able provide sufficient number organ patient wait list . We therefore suggest new pancreas allocation system donor age 50-60 year BMI 30-34 allocate regionally within cold ischemic time &lt; 12 h. To prove hypothesis extend pancreas allograft donor use safely equal outcome recipient prospective comparative multicenter feasibility-study require . A good example successful change allocation rule European Senior Donor Program ( ESDP ) kidney , call `` old old '' program . Within program kidney donor &gt; 65 year allocate regionally patient &gt; 65 year relatively short ischemic time without HLA matching . For purpose comparative study perform prove efficacy allocation change . The standard immunosuppression SPK PTA include induction therapy antibody . Maintenance therapy mostly perform tacrolimus / mycophenolate mofetil combination . The usage calcineurin inhibitor maintenance therapy characterize clear transition cyclosporine tacrolimus . Myfortic® v . Cell Cept® show beneficial effect SPK large single center comparison . Corticosteroids administer majority patient ; however , steroid-avoidance steroid-withdrawal protocol increasingly common .</detailed_description>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Recipients standard allocation organ Recipients organs donor 50 60 year OR BMI 3034 CIT ( cold ischemic time ) ≤ 12h ( local allocation organ , optimally procure surgical team transplant team ) . negative crossmatch age &gt; 18 year primary SPK , PAK PTA Patients standardize immunosuppressive treatment Tacrolimus ( Prograf® ) , MPA ( Myfortic® ) [ aim center specific troughlevel practice ] day 5 transplantation ( prior day 5 MMF ( Cell Cept® ) apply i.v . medication due reduce gastrointestinal passage insecure absorption orally applied medication ) centerspecific steroid treatment . Malignant disease within 5 year prior PTA/SPK except squamous cell carcinoma basalioma skin . Pancreas retransplantation . Immunized patient preform antibody titer &gt; 5 % . Women child bear potential . Patients psychological , familial , sociologic geographic condition potentially hamper compliance study protocol followup schedule . Patients guardianship ( e.g . individual able freely give informed consent ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Pancreas transplantation</keyword>
	<keyword>extend donor criterion</keyword>
	<keyword>organ survival</keyword>
</DOC>